 OSLO, Norway--BUSINESS WIRE--- ULTI 1Q21--Ultimovacs ASA Ultimovacs, ticker ULTI, a pharmaceutical company developing novel immunotherapies against cancer, announces its first quarter 2021 results today. A presentation by the Companys management team will take place today on a webcast at 09:00 CEST. The presentation can be followed as a live webcast, which will also be available on our website. Highlights for the first quarter of 2021: In the INITIUM trial, 40 patients have been enrolled as per the r 